Variant report
Variant | esv1796017 |
---|---|
Chromosome Location | chr3:86549098-86566458 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143293940 | chr3:86551248-86551249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111391639 | chr3:86551282-86551283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs13433845 | chr3:86551288-86551289 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs151261674 | chr3:86551348-86551349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185048156 | chr3:86551361-86551362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569860294 | chr3:86551378-86551379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1845433 | chr3:86551381-86551382 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs1845434 | chr3:86551403-86551404 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs567219513 | chr3:86551444-86551445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187969000 | chr3:86551455-86551456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140533004 | chr3:86551505-86551506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577594321 | chr3:86551612-86551613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538941998 | chr3:86551624-86551625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145620301 | chr3:86551637-86551638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533285210 | chr3:86551651-86551652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192823675 | chr3:86551655-86551656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185212481 | chr3:86551678-86551679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561547044 | chr3:86551700-86551701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372933907 | chr3:86551711-86551712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541742842 | chr3:86551763-86551764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1494302 | chr3:86560619-86560620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs113562441 | chr3:86560654-86560655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575282613 | chr3:86560659-86560660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11923446 | chr3:86560727-86560728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574146245 | chr3:86560736-86560737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552828073 | chr3:86560798-86560799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184337325 | chr3:86560820-86560821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs55936684 | chr3:86560843-86560844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536770229 | chr3:86560860-86560861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138706421 | chr3:86560868-86560869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188692793 | chr3:86560916-86560917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200693170 | chr3:86560929-86560930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs556500854 | chr3:86560934-86560935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79531038 | chr3:86560944-86560945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372350284 | chr3:86560964-86560965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544001972 | chr3:86560989-86560990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113163400 | chr3:86561015-86561016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554527019 | chr3:86561020-86561021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560934835 | chr3:86561021-86561022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540004779 | chr3:86561037-86561038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574526186 | chr3:86561049-86561050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534538997 | chr3:86561073-86561074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17027789 | chr3:86561075-86561076 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs372468684 | chr3:86561080-86561081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6779242 | chr3:86561143-86561144 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs141158569 | chr3:86561144-86561145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373885062 | chr3:86561164-86561165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562493482 | chr3:86561203-86561204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565569513 | chr3:86561213-86561214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150727655 | chr3:86561312-86561313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:86551200-86551800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr3:86560600-86561200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr3:86560600-86561400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr3:86561200-86562200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr3:86562200-86562400 | Enhancers | HUES48 Cell Line | embryonic stem cell |